It's not just AI. Nine startups joined the so-called unicorn club around the world in February, including three in the Bay ...

NEW YORK (Reuters) -The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by ...

Shares of Cassava Sciences SAVA plunged 32.1% on Tuesday after the company announced that its lead pipeline candidate, ...

President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC ...

Cassava Sciences is ending simufilam development for Alzheimer's after Phase 3 trials failed. The company is shifting focus ...

Cassava said that it will discontinue all efforts to develop simufilam and expects to phase out the program by the end of the second quarter. Still, the biotechnology company said it has begun ...

Cassava Sciences has given up on simufilam in Alzheimer’s disease. | Cassava Sciences has given up on simufilam in ...

Cassava Technologies and Nvidia will collaborate to power Africa’s first artificial intelligence factory. Nvidia Corp. has ...

A new soda pop containing a mixture of prebiotics to encourage bacterial diversity is now available. Currently, there is no ...

A research team investigates how genome editing can be harnessed to accelerate cassava breeding and improve key traits.

We recently published a list of 10 Best Short-Term Stocks To Buy Right Now. In this article, we are going to take a look at ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Apple has almost one billion subscribers on its services. In total, 975 million users ...